default author photo

Jung Won Woo

Genexine, Inc.

SCHOLARLY PAPERS

1

DOWNLOADS

95

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

GX-188E DNA Vaccine Plus Pembrolizumab as a 2nd Line Treatment for HPV 16- and/or 18-Positive, PD-L1 All-Comer Recurrent or Advanced Cervical Cancer: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial

Number of pages: 32 Posted: 02 Jan 2024
Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Catholic University of Korea, Catholic University of Korea, University of Ulsan - Asan Medical Center, Seoul National University - Seoul National University Bundang Hospital, Sungkyunkwan University - Samsung Medical Center, Keimyung University Dongsan Medical Center, Yonsei University - College of Medicine, Inje University, Korea University, Chinese Academy of Medical Sciences - Center for Gynecologic Cancer, Genexine, Inc., Genexine, Inc., Pohang University of Science and Technology (POSTECH) and Catholic University of Korea
Downloads 95 (720,278)

Abstract:

Loading...